Dr. Suraj Kapa

Dr. Suraj Kapa received his BA in Mathematics from Drew University in New Jersey before receiving his medical degree from the University of Medicine & Dentistry of New Jersey. Subsequently, Dr. Kapa completed his residency at Mayo Clinic where his research focused on defining the nature of background genetic noise in long QT syndrome, defining novel cell types and ion channels in the heart, population studies of sudden cardiac death, and device innovation primarily in the areas of non-invasive electrophysiology imaging and dynamic non-invasive ablation. He is currently completing his subspecialty training in cardiac electrophysiology at the Perelman School of Medicine at the University of Pennsylvania.

Dr. Kapa’s work in medical innovation has resulted in several disclosures, which are currently in the patent process, and numerous industry collaborations. These and other grant-funded projects culminated in him receiving  the outstanding research award by the Mayo Clinic and a young investigator award by the Sudden Arrhythmic Death Syndrome foundation, as well as being invited to several domestic and international lectures. As a senior resident at Mayo Clinic, Dr. Kapa was named an assistant professor in medicine in recognition of his work.

Prior to completing residency, Dr. Kapa was named the president and chief medical officer of the Radio Frequency Identification in Healthcare Consortium (RHCC) in credit of the work he has done related to researching electromagnetic interference with wireless technologies in healthcare. During his cardiology fellowship at the Hospital of the University of Pennsylvania, he has continued research in the area of electrophysiology including industry-sponsored prospective trials and collaborative research with the Children's Hospital of Pennsylvania and the Mayo Clinic.

Dr. Kapa also served in national roles on the Education Committee for the Heart Rhythm Society and as a principal member of writing groups for the NIH-NHLBI related to sleep apnea in cardiovascular disease, and the ACC related to the development of new appropriate use criteria recommendations. These efforts have contributed to his publishing numerous original articles as well as book chapters in texts including "Braunwald's Heart Disease to Therapy" in Nephrology and Hypertension.